News Detail
Your location:
Homepage
/
/
China's anti-COVID-19 drug enters late-stage human trial

China's anti-COVID-19 drug enters late-stage human trial

  • Categories:News Center
  • Author:
  • Origin:Xinhua
  • Time of issue:2021-12-13
  • Views:0

(Summary description)China's anti-COVID-19 drug enters late-stage human trial

China's anti-COVID-19 drug enters late-stage human trial

(Summary description)China's anti-COVID-19 drug enters late-stage human trial

  • Categories:News Center
  • Author:
  • Origin:Xinhua
  • Time of issue:2021-12-13
  • Views:0
Information

BEIJING -- A Chinese antiviral medicine for COVID-19, called JS016, has commenced phase-3 clinical trials overseas, its developer said Monday.

The patented anti-COVID-19 drug candidate was jointly developed by the Institute of Microbiology under the Chinese Academy of Sciences and the Shanghai Junshi Biosciences Co., Ltd.

In June 2020, China's drug regulator granted permission to the developers to carry out human tests.

According to the institute, JS016 has become the first COVID-19 monoclonal antibody in the world to carry out clinical trials in healthy people.

Researchers completed global multi-center phase-2 trials this month. The results of the early-stage trials support the safety and effectiveness of JS016, suggesting it can lower the viral titer in participants and reduce the risk of becoming a severe case.

"The drug has been used for emergency treatment in 15 countries, and more than 500,000 doses have been sent overseas," said Yan Jinghua, a researcher with the Institute of Microbiology.

China's Ministry of Science and Technology has also allocated 3,000 doses of the drug for the treatment of COVID-19 patients in the country, Yan added.

Scan the QR code to read on your phone

Other Dynamics

TUV CE0197 certificate
Detail 白箭头 黑箭头
Munich Shanghai Analytical Biochemistry Exhibition
Detail 白箭头 黑箭头
US coronavirus deaths hit 1 million: a tragedy that will forever be in the history books
Detail 白箭头 黑箭头

CIDA (GUANGZHOU) BIOTECHNOLOGY CO., LTD. 

这是描述信息

Hotline: +86-20-31601519、+86-13580561466
E-mail: sales@cidahealth.com
Address: Room 503, Building D, No. 7, Jingye 3rd Street, Yushu Industrial Park, Science City, Huangpu District, Guangzhou, Guangdong, China

 

PRODUCTS CENTER

这是描述信息

GUESTBOOK

这是描述信息
Username used for comment:
底部留言
Description:

Copyright 2021© CIDA (Guangzhou) Biotechnology Co., Ltd.   All Rights
粤ICP备19025968号  www.300.cn